Institutional members access full text with Ovid®

Share this article on:

Epigenetic regulation of death-associated protein kinase expression in primary gastric cancers from Chinese patients

Ye, Meia; Li, Dongqingb; Zhou, Fenga; Guo, Qiushaa; Xia, Binga

European Journal of Cancer Prevention: May 2012 - Volume 21 - Issue 3 - p 241–246
doi: 10.1097/CEJ.0b013e32834c9caa
Research Papers: Colorectal cancer

Death-associated protein kinase (DAPK) is a novel serine/threonine kinase involved in apoptosis and tumor suppression. Promoter methylation is an important mechanism by which tumor suppressor gene transcription is repressed in cancer cells. Although reduced expression and aberrant methylation of DAPK has been reported in various human cancers, including gastric cancer (GC), the results remain discrepant. We aimed to investigate DAPK mRNA and protein expression in primary GC tissues from Chinese patients and establish a possible relationship between the promoter methylation status and the decreased expression of DAPK. The mRNA level, protein expression, and promoter methylation of DAPK were examined, in the cancer tissues and the corresponding, adjacent nontumor tissues of the 62 GC cases, by RT-PCR, western blotting and methylation-specific PCR, respectively. DAPK mRNA and protein expression in GC tissues was significantly reduced compared with corresponding nontumor tissues (P<0.0001). The methylation frequency of the DAPK promoter in primary GC tissues is significantly higher than in the corresponding nontumor tissues (54.8 vs. 17.7%, P<0.0001). Furthermore, DAPK mRNA expression in tissues containing aberrant promoter methylation was significantly reduced compared with GC tissues with unmethylated DAPK promoter (P<0.0001). Moreover, a significant correlation was demonstrated between the TNM stage and the degree of DAPK promoter methylation in primary GCs (P=0.04). DAPK protein and mRNA expression was reduced in GC tissues of Chinese patients. Diminished expression of DAPK was associated with promoter methylation.

aDepartment of Gastroenterology, Hubei Clinical Centre & Key Laboratory of Intestinal and Colorectal Diseases, Zhongnan Hospital of Wuhan University School of Medicine

bDepartment of Microbiology, Wuhan University School of Basic Medical Sciences, Wuhan 430071, Hubei Province, People’s Republic of China

Correspondence to Dr Bing Xia, MD, PhD, Department of Gastroenterology, Zhongnan Hospital of Wuhan University School of Medicine, Wuhan 430071, Hubei, People’s Republic of China Tel: +86 27 67813072; fax: +86 27 67812892; e-mail:

Received May 18, 2011

Accepted July 16, 2011

© 2012 Lippincott Williams & Wilkins, Inc.